Transforming Medicine through Preventive Genomics

2:00 - 2:50 PM
The power of preventive genomic testing is transforming medicine at Brigham and Women’s Hospital. Hear from experts who are using this technology to enhance healthcare, and from patients who have received lifesaving information from an unexpected source: their own DNA.

ABOUT THE SESSION

This exciting session will kick off with a lively 15-minute TED-style talk by Dr. Robert Green, a leading medical geneticist and director of the new Preventive Genomics Clinic at Brigham and Women’s Hospital. In this new clinic, healthy patients can obtain advanced genetic testing, including whole genome sequencing, that can identify future disease risks and offer life-saving preventive strategies. The audience will hear about the power of genomic information, and how this technology is being integrated into medical practice at BWH.

The presentation will be followed by a 15-minute interview with several patients who will describe in-person how they have received unanticipated genetic results leading to medical interventions through some of the ongoing research studies at Brigham. This will include adults and parents of newborns who are among the first in the world to have themselves, and their infants, sequenced with reporting of comprehensive results from thousands of genes.     

The session will conclude with a 20-minute panel discussion that includes the patients, Dr. Joel Krier, clinical chief of the Genetics Division and director of the Pharmacogenomics Clinic, along with Roseann Gammal, an assistant professor of pharmacy and Pharmacogenomics Clinical Specialist. These experts and patients will discuss genomic testing currently available to enhance healthcare at BWH, and audience members will be encouraged to ask questions and discuss the topic of preventive genomics.     

CHAIR / MODERATOR

Robert Green, MD, MPH

Associate Physician, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School
Geneticist, Brigham and Women’s Hospital
Director, Genomes2People Research Program

CHAIR / PANELIST

Joel Krier, MD, MMSc, FACMG

Assistant Professor, Harvard Medical School
Medical Director of M.S in Genetic Counseling, MGH Institute of Health Professions
Associate Professor, MGH Institute of Health Professions
Clinical Chief of the Division of Genetics, Brigham and Women’s Hospital

PANELISTS

Roseann Gammal, PharmD

Assistant Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences (MCPHS)

SPEAKERS

JOEL KRIER, MD, MMSC, FACMG

Assistant Professor, Harvard Medical School
Medical Director of M.S in Genetic Counseling, MGH Institute of Health Professions
Associate Professor, MGH Institute of Health Professions
Clinical Chief of the Division of Genetics, Brigham and Women’s Hospital

Dr. Krier is Clinical Chief of the Division of Genetics at Brigham & Women’s Hospital, Director of Brigham Genomic Medicine, and Assistant Professor, Medicine, at Harvard Medical School. Dr. Krier is an investigator on the NIH Undiagnosed Diseases Network Project and past co-investigator on the NIH-funded MedSeq and ClinGen Projects, internationally known genomic medicine initiatives. He is also Medical Director of the Master of Science in Genetic Counseling program at MGH Institute of Health Professions.

ROBERT GREEN, MD, MPH

Associate Physician, Brigham and Women’s
Hospital Professor of Medicine, Harvard Medical School
Geneticist, Brigham and Women’s Hospital Director, Genomes2People Research Program

Dr. Green is Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital and the Broad Institute. Dr. Green is internationally recognized for research and policy efforts accelerating the implementation of genomic/precision medicine. He also directs the Preventive Genomics Clinic at Brigham Health, the first such clinic in the world to provide evidence-based genomic and multi-omics evaluation to early adopters seeking to anticipate and prevent future illness.

ROSEANN GAMMAL, PHARMD

Assistant Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences (MCPHS)

Roseann S. Gammal is an Assistant Professor of Pharmacy Practice at MCPHS University and a Board Certified Pharmacotherapy Specialist (BCPS) with interests in both pharmacogenomics and pediatrics. She is published in the field of pharmacogenomics and has presented on pharmacogenomics topics to national and international audiences. She serves as a Pharmacogenomics Clinical Specialist for the Clinical Pharmacogenetics Implementation Consortium, an NIH-funded organization that creates evidence-based guidelines describing how to use pharmacogenetic test results to optimize medication therapy.